0 CHECKOUT

PRODUCT FILTERS

CATEGORIES

  • 23
  • 19
  • 10
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1

PRICE

0
1
50
67

PUBLISHED

0
7
33
67

PRODUCT TYPE

67

Search for: "Hanmi Pharmaceutical Company Limited-Therapeutic Competitors Report"

67 Products

Type 2 Diabetes - Pipeline Review, H2 2014

Type 2 Diabetes - Pipeline Review, H2 2014 Summary This, ‘Type 2 Diabetes - Pipeline Review, H2 2014’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides comprehensive...

Published:  October 2014
Price:  From

Gastric Cancer - Pipeline Review, H1 2015

Gastric Cancer - Pipeline Review, H1 2015 Summary: This, ‘Gastric Cancer - Pipeline Review, H1 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline. This report provides...

Published:  March 2015
Price:  From

Hypertension - Pipeline Review, H1 2015

Hypertension - Pipeline Review, H1 2015 Summary the, ‘Hypertension - Pipeline Review, H1 2015’, provides an overview of the Hypertension’s therapeutic pipeline. This report provides comprehensive...

Published:  June 2015
Price:  From

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014 Summary This, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014’, provides an overview of the Chemotherapy Induced Neutropenia’s...

Published:  November 2014
Price:  From

Dyslipidemia - Pipeline Review, H1 2015

Dyslipidemia - Pipeline Review, H1 2015 Summary This, ‘Dyslipidemia - Pipeline Review, H1 2015’, provides an overview of the Dyslipidemia’s therapeutic pipeline. This report provides comprehensive...

Published:  January 2015
Price:  From

Colon Cancer - Pipeline Review, H1 2014

Colon Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2014’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides...

Published:  February 2014
Price:  From

Competitor Analysis: Erythropoietin (EPO)

The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second generation...

Published:  January 2011
Price:  From

Obesity - Pipeline Review, H1 2015

Obesity - Pipeline Review, H1 2015 Summary This, ‘Obesity - Pipeline Review, H1 2015’, provides an overview of the Obesity’s therapeutic pipeline. This report provides comprehensive information on...

Published:  February 2015
Price:  From

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2014

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review,...

Published:  March 2014
Price:  From

Hyperlipidemia - Pipeline Review, H1 2014

Hyperlipidemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hyperlipidemia - Pipeline Review, H1 2014’, provides an overview of the Hyperlipidemia’s therapeutic pipeline. This report...

Published:  April 2014
Price:  From

Obesity - Pipeline Review, H2 2014

Obesity - Pipeline Review, H2 2014 Summary This, ‘Obesity - Pipeline Review, H2 2014’, provides an overview of the Obesity’s therapeutic pipeline. This report provides comprehensive information on...

Published:  September 2014
Price:  From

Women Infertility - Pipeline Review, H1 2014

Women Infertility - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Women Infertility - Pipeline Review, H1 2014’, provides an overview of the Women Infertility’s therapeutic pipeline. This...

Published:  February 2014
Price:  From

Hypertension - Pipeline Review, H1 2014

Hypertension - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2014’, provides an overview of the Hypertension’s therapeutic pipeline. This report provides...

Published:  February 2014
Price:  From

Type 2 Diabetes - Pipeline Review, H1 2014

Type 2 Diabetes - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2014’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This...

Published:  February 2014
Price:  From

Cough - Pipeline Review, H1 2014

Cough - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cough - Pipeline Review, H1 2014’, provides an overview of the Cough’s therapeutic pipeline. This report provides comprehensive...

Published:  March 2014
Price:  From

Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

Non-Small Cell Lung Cancer - Pipeline Review, H1 2015 Summary the, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic pipeline. This...

Published:  June 2015
Price:  From

Gastric Cancer - Pipeline Review, H2 2014

Gastric Cancer - Pipeline Review, H2 2014 Summary This, ‘Gastric Cancer - Pipeline Review, H2 2014’, provides an overview of the Gastric Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  November 2014
Price:  From

Hypertension - Pipeline Review, H2 2014

Hypertension - Pipeline Review, H2 2014 Summary This, ‘Hypertension - Pipeline Review, H2 2014’, provides an overview of the Hypertension’s therapeutic pipeline. This report provides comprehensive...

Published:  August 2014
Price:  From

Colon Cancer - Pipeline Review, H2 2014

Colon Cancer - Pipeline Review, H2 2014 Summary This, ‘Colon Cancer - Pipeline Review, H2 2014’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  October 2014
Price:  From

Irritable Bowel Syndrome - Pipeline Review, H2 2014

Irritable Bowel Syndrome - Pipeline Review, H2 2014 Summary This, ‘Irritable Bowel Syndrome - Pipeline Review, H2 2014’, provides an overview of the Irritable Bowel Syndrome’s therapeutic pipeline. This...

Published:  September 2014
Price:  From
Loading Indicator

Our Clients

  • Glanbia Plc.
  • Unilever N.V.
  • Microsoft Corporation
  • Duke University
  • A.T. Kearney
  • PepsiCo Inc.
  • Boston Consulting Group